Loss of Nectin-3 expression in PanNETs was associated with larger tumor size, a higher grade, lymphatic involvement, a higher Ki67 labeling index, an advanced pT-factor, lymph node metastasis, an advanced tumor stage, nonfunctioning tumors, and shorter disease-free survival. The gene discussed is NECTIN3; the disease is neoplasm.